Detalhe da pesquisa
1.
Discontinuation of immune checkpoint inhibitor (ICI) above 18 months of treatment in real-life patients with advanced non-small cell lung cancer (NSCLC): INTEPI, a multicentric retrospective study.
Cancer Immunol Immunother
; 71(7): 1719-1731, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34821950
2.
Severe Pulmonary and Nasopharyngeal Candida krusei Infection in Cocaine-induced Vasculopathy.
Am J Respir Crit Care Med
; 209(5): 587-589, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38207072
3.
Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial.
Eur Respir J
; 52(4)2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30262574
4.
Development and validation of a host-dependent, PDL1-independent, biomarker to predict 6-month progression-free survival in metastatic non-small cell lung cancer (mNSCLC) patients treated with anti-PD1 immune checkpoint inhibitors (ICI) in the CERTIM Cohort: The ELY study.
EBioMedicine
; 73: 103630, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34688030
5.
The impact of body composition parameters on severe toxicity of nivolumab.
Eur J Cancer
; 124: 170-177, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31794927
6.
Is there an Exposure-Response Relationship for Nivolumab in Real-World NSCLC Patients?
Cancers (Basel)
; 11(11)2019 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31766292
7.
Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patients.
J Pharm Biomed Anal
; 158: 174-183, 2018 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29883880
8.
[Pharmacological treatment of stable chronic obstructive pulmonary disease]. / Traitement médicamenteux de la bronchopneumopathie chronique obstructive en état stable.
Presse Med
; 38(3): 432-44, 2009 Mar.
Artigo
em Francês
| MEDLINE | ID: mdl-19171453
9.
Lobectomy with pulmonary artery resection: morbidity, mortality, and long-term survival.
J Thorac Cardiovasc Surg
; 137(6): 1400-5, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19464456